VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
42 hedge funds and large institutions have $5.61M invested in Viracta Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
44% less capital invested
Capital invested by funds: $10.1M → $5.61M (-$4.47M)
Holders
42
Holding in Top 10
1
Calls
$1K
Puts
–
Top Buyers
| 1 | +$96.1K | |
| 2 | +$65.2K | |
| 3 | +$23.6K | |
| 4 |
Squarepoint
New York
|
+$20.6K |
| 5 |
Renaissance Technologies
New York
|
+$17.5K |
Top Sellers
| 1 | -$77K | |
| 2 | -$55K | |
| 3 | -$38K | |
| 4 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$24.1K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$18K |